Sandy Primrose

Sandy Primrose has degrees from the University of Strathclyde, Scotland, and the University of California at Davis. He has spent over 40 years in senior management roles in the pharmaceutical, diagnostic and biotechnology industries. Currently he is Chairman of AMLo Biosciences and Newcells Biotech and more recently Chairman of Arquer Diagnostics and Non-Executive Director of Mologic.